Summary & Overview
CPT 51597: Pelvic Exenteration for Bladder, Prostatic, or Urethral Malignancy
CPT code 51597 represents an extensive pelvic exenteration — a bloc resection of pelvic organs performed for invasive urologic malignancies such as bladder, prostatic, or urethral cancer. This high-complexity surgical code captures multi-organ resection often involving the bladder, lower ureters, urethra, regional lymph nodes, and adjacent reproductive organs. It is nationally important because it documents care for advanced pelvic cancers that typically require inpatient resources, multidisciplinary surgical teams, and significant perioperative support.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context, typical sites of service, common billing modifiers, and payer coverage considerations. The publication summarizes national benchmarks for service utilization and reimbursement patterns where available, highlights coding and documentation points relevant to complex oncologic pelvic surgery, and outlines the clinical scenarios in which CPT code 51597 is commonly reported. Data not provided in the input (such as specific associated taxonomies, ICD-10 diagnoses, related codes, and detailed payer-specific rates) are noted as unavailable and excluded from tables.
Billing Code Overview
CPT code 51597 describes an extensive pelvic exenteration procedure in which the surgeon performs bloc resection of pelvic organs. The operation may include removal of the bladder, lower ureters, urethra, and regional lymph nodes, and in females may include the uterus, cervix, and vagina, or in males may include the prostate. The description indicates this procedure is performed for patients with bladder, prostatic, or urethral malignancy.
Service Type: Extensive pelvic oncologic surgical resection (pelvic exenteration)
Typical Site of Service: Hospital operating room / inpatient surgical setting
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old male with muscle-invasive bladder cancer presenting with hematuria, pelvic pain, and imaging showing a large, locally advanced tumor involving the bladder and distal ureters with suspected regional lymph node involvement. After multidisciplinary tumor board review, the patient is selected for an extended pelvic exenteration (CPT 51597) due to tumor invasion of adjacent pelvic organs. Preoperative workup includes cross-sectional imaging (CT chest/abdomen/pelvis), cystoscopy with biopsy confirming high-grade urothelial carcinoma, cardiopulmonary clearance, and counseling regarding urinary diversion options (ileal conduit or continent diversion) and potential need for colostomy.
In the operating room, a urologic oncologist and colorectal surgeon perform a radical en bloc pelvic resection that may include radical cystectomy, removal of the prostate and seminal vesicles in males (or uterus, cervix, and upper vagina in females), distal ureters, adjacent portion of rectum or colon if involved, and pelvic lymphadenectomy. Reconstruction includes urinary diversion (commonly an ileal conduit) and, if needed, bowel resection with anastomosis or colostomy. Postoperative management is in an inpatient setting with intensive monitoring for bleeding, infection, ileus, and stoma care. Pathology guides adjuvant therapy decisions including chemotherapy or radiation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |